March 3, 2020 
The National Institute on Drug Abuse (NIDA) has just alerted the research community that populations with Substance Use Disorders may be more susceptible to coronavirus. On Monday, the Substance Abuse and Mental Health Services Administration (SAMHSA) posted COVID-19 guidance providing potential flexibility for opioid treatment programs.
CADCA is proud to present the prestigious International Leadership Award to the Association of Anti-Drug Abuse Coalitions of the Philippines Inc. (AADAC PHL)
CADCA’s Public Policy (PP) team has developed case studies, which showcase coalitions that have exceptional outcome data.
The Blue Ribbon Coalition Initiative, driven by CADCA and the National Coalition Institute (NCI) with funding from the Office of National Drug Control Policy (ONDCP), is officially accepting applications for 2024!
Get involved. Let's improve prevention for
everyone globally– and build lasting impact.
